Leuk Lymphoma. 2013 Feb;54(2):304-9. doi: 10.3109/10428194.2012.710904. Epub 2012 Sep 8.
Tertiary center referral patterns for patients with myelodysplastic syndrome are indicative of age and race disparities: a single-institution experience.
Zandberg DP, Hendrick F, Vannorsdall E, Bierenbaum J, Tidwell ML, Ning Y, Zhao XF, Davidoff AJ, Baer MR.
SourceUniversity of Maryland Greenebaum Cancer Center, Baltimore, MD 21201, USA.
Little is known about disparities in myelodysplastic syndromes (MDS). We performed a retrospective chart review of patients with MDS (n = 252) evaluated at the University of Maryland Greenebaum Cancer Center between 2000 and 2010. The median age at diagnosis was 65 years, which was lower than the median age of 76 years for patients with MDS in the Surveillance, Epidemiology and End Results database. Black males were younger than white males (62 vs. 68 years; p = 0.03) and had longer time to referral (9 vs. 1.5 months; p = 0.03), but black and white females did not differ in age or in time to referral. A difference in World Health Organization subtype classification was noted in black and white patients at diagnosis, but not at referral. There was no difference between all other pretreatment characteristics, treatment and survival by race. Our data suggest barriers to tertiary care referral for older patients and for black males.
- Beyond race-related disparities: is myelodysplastic syndrome the same everywhere? [Leuk Lymphoma. 2013]
- The race for survival in myelodysplastic syndromes. [Leuk Lymphoma. 2013]
- [PubMed - indexed for MEDLINE]